Your search history is turned on.
Date: April 29, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Statement of Executive Compensation (00041085.DOCX;3) {00041085:3} EASTWOOD BIO-MEDICAL CANADA INC. (the Company) Form 51-102F6V STATEMENT OF EXECUTIVE COMPENSATION (for the financial year ended October 31, 2023) The following information is provided in accordance with National Instrument Form 51-102F6V Statement of Executive ...
Date: April 2, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Yunji Kim, Chief Financial Officer of Eastwood Bio-Medical Canada Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Eastwood Bio-Medical Canada Inc. (the issuer) for the interim period ended Janua...
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Youngsoo Kim, Chief Executive Officer of Eastwood Bio-Medical Canada Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Eastwood Bio-Medical Canada Inc. (the issuer) for the interim period ended January 31...
1 GENERAL Set out below is a review of the activities, results of operations and financial position of Eastwood Bio-Medical Canada Inc. (EBMC or the Company). This Managements Discussion and Analysis (MD&A), dated as of March 30, 2024 should be read in conjunction with the financial statements of the Company for the period ended January 31, 2024, and the related n...
EASTWOOD BIO-MEDICAL CANADA INC. CONDENSED INTERIM FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED JANUARY 31, 2024 (Expressed in Canadian Dollars) EASTWOOD BIO-MEDICAL CANADA INC. FOR THE THREE MONTHS ENDED JANUARY 31, 2024 Table of contents Notice of the reader...
Date: February 28, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, Yunji Kim, Chief Financial Officer of Eastwood Bio-Medical Canada Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that a...
Microsoft Word - EBM FY 2021 CEO Cert Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, Youngsoo Kim, Chief Executive Officer of Eastwood Bio-Medical Canada Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and in...
Date: February 28, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, KIM, Yunji, an officer of the reporting issuer noted below have examined this Form 13-502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonable di...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...
Microsoft Word - 2023 MD&A Eastwood 1 GENERAL Set out below is a review of the activities, results of operations and financial position of Eastwood Bio-Medical Canada Inc. (EBMC or the Company). This Managements Discussion and Analysis (MD&A), dated as of February 28, 2024 should be read in conjunction with the audited financial statements of th...